This letter refutes the “overdiagnosis” narrative, blaming the stimulant shortage on DEA regulatory failures, clinical constraints, and recognition of historical underdiagnosis. By concluding that ...
Publication of the final results of the field trials for the upcoming Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has prompted renewed criticism from one of its most ...
The American Psychiatric Association has never once addressed the substantive questions raised about DSM 5. Instead, it has always followed the Public Relations recommendation to endlessly repeat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results